Featured Content
Before Ziya Gokaslan, MD, enters the operating room, he increasingly wants the operation to have happened once already. Not on…
Most Read
The Latest
Picture the months after an AI rollout in patient access: clinicians working around the tool instead of with it, a workflow that looked seamless in the demo now creating new friction and a nagging question about whether patients are actually…
- Sunny Eappen, MD, Chief Medical Officer, Assort Health
Picture the months after an AI rollout in patient access: clinicians working around the tool instead of with it, a workflow that looked seamless in the demo now creating new friction and a nagging question about whether patients are actually…
Presented by:
- Sunny Eappen, MD, Chief Medical Officer, Assort Health
Healthcare transformation is accelerating, but the workforce needed to support it is struggling to keep pace. As health systems invest in digital infrastructure, AI, and new care delivery models, leaders are facing a fundamental challenge: the talent required to operate…
Presented by:
- Luisa Kurtz, DVP Sales, Leadership Solutions, AMN Healthcare
- Tanner Burch, Vice President, Advisory Services, AMN Healthcare
Implementing new technologies, moving away from paper forms and reviewing fixed costs on a regular basis are three ways that orthopedic practices and surgeons are working to reduce costs. As operating costs climb and reimbursements continue to decline, practices have…
Here are six new spine and orthopedic biologics that have launched, earned FDA approval or received additional clearances, as reported by Becker’s in the first half of 2026. Note: This list is not exhaustive.
The Chattanooga, Tenn.-based Center for Sports Medicine and Orthopedics is transitioning some of its procedures to a new health system, according to a July 9 report from ABC affiliate News Channel 9. Currently, the practice completes the majority of its…
Spine surgery has historically operated under two sets of economics: one determined by the care delivered and another by the building in which it is delivered. For 2026, Medicare’s ASC conversion factor is $56.322, compared with $91.415 for hospital outpatient…
A company-published meta-analysis found allogeneic umbilical cord-derived stem cell therapy was associated with lower knee osteoarthritis pain scores at 12 months than corticosteroid and hyaluronic acid injections, the current non-surgical standard. Longevity Medical Institute published the peer-reviewed review July 6…
Health system pharmacy leaders invest heavily in training their teams. What that investment rarely reveals is whether those teams are ready to perform when a situation demands more than process knowledge. Traditional models were built to move people through a…
- Michael Alexander, Co-Founder, Audirie
- Dr. Tina Moan, PharmD, Chief Pharmacy Officer, Colibri Healthcare
Most practice leaders believe denials are under control. New data tells a different story. In a survey of 360 independent practices, only 1 in 4 could pinpoint where revenue was leaking, and denials were climbing for nearly half. The reason…
Presented by:
- Ian Maurer, VP, Veradigm
Popular in Spine
The EVS single-use debate is shifting: what the data means for cost and sustainability
Presenter: Brooke Hossfeld, MPH, CIC, MLS (ASCP)CM, Sodexo Healthcare
Becker’s offerings
-
Events
Where healthcare leaders meet — see what’s coming up.
View All Events
-
Webinars
Explore and register for webinars across a wide variety of topics.
View All Webinars
-
Whitepapers
Gain valuable insights & knowledge from our leading industry experts.
View All Whitepapers
-
Podcasts
Listen to interviews and conversations on healthcare’s most pressing issues.
View All Podcasts